PLN 178.8
(-0.33%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 516 Thousand PLN | 27.72% |
2022 | 404 Thousand PLN | 0.0% |
2021 | - PLN | 0.0% |
2020 | - PLN | 0.0% |
2019 | - PLN | 0.0% |
2018 | - PLN | -100.0% |
2017 | 1800.00 PLN | -99.02% |
2016 | 183.23 Thousand PLN | -95.93% |
2015 | 4.5 Million PLN | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 37 Thousand PLN | 362.5% |
2024 Q2 | 50 Thousand PLN | 35.14% |
2023 Q3 | 3000.00 PLN | -93.33% |
2023 Q2 | 45 Thousand PLN | -90.22% |
2023 Q1 | 460 Thousand PLN | 13.86% |
2023 FY | 516 Thousand PLN | 27.72% |
2023 Q4 | 8000.00 PLN | 166.67% |
2022 Q1 | - PLN | 0.0% |
2022 Q3 | - PLN | 0.0% |
2022 Q4 | 404 Thousand PLN | 0.0% |
2022 Q2 | - PLN | 0.0% |
2022 FY | 404 Thousand PLN | 0.0% |
2021 Q1 | - PLN | 0.0% |
2021 FY | - PLN | 0.0% |
2021 Q2 | - PLN | 0.0% |
2021 Q3 | - PLN | 0.0% |
2021 Q4 | - PLN | 0.0% |
2020 Q3 | - PLN | 0.0% |
2020 FY | - PLN | 0.0% |
2020 Q1 | - PLN | 0.0% |
2020 Q2 | - PLN | 0.0% |
2020 Q4 | - PLN | 0.0% |
2019 Q4 | - PLN | 0.0% |
2019 Q3 | - PLN | 0.0% |
2019 Q2 | - PLN | 0.0% |
2019 Q1 | - PLN | 0.0% |
2019 FY | - PLN | 0.0% |
2018 Q2 | - PLN | 0.0% |
2018 FY | - PLN | -100.0% |
2018 Q4 | - PLN | 0.0% |
2018 Q3 | - PLN | 0.0% |
2018 Q1 | - PLN | 0.0% |
2017 Q2 | 1800.00 PLN | 100.0% |
2017 Q3 | - PLN | -100.0% |
2017 Q4 | - PLN | 0.0% |
2017 FY | 1800.00 PLN | -99.02% |
2017 Q1 | 900.00 PLN | -64.75% |
2016 Q2 | 126.7 Thousand PLN | 42.27% |
2016 Q3 | 5105.76 PLN | -95.97% |
2016 Q4 | 2553.00 PLN | -50.0% |
2016 FY | 183.23 Thousand PLN | -95.93% |
2016 Q1 | 89.06 Thousand PLN | 0.0% |
2015 FY | 4.5 Million PLN | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
BioMaxima S.A. | 46.78 Million PLN | 98.897% |
Selvita S.A. | 346.95 Million PLN | 99.851% |
Voxel S.A. | 424.18 Million PLN | 99.878% |